IL17A and rheumatoid arthritis: In the context of hydroxychloroquine, when this compound is introduced to peripheral blood mononuclear cells from RA patients in vitro, there is a decrease in the secretion of IL-17, IL-6, and IL-22 in the culture supernatant (108).